High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer
Author:
Affiliation:
1. Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
2. Department of Research Management and International Cooperation, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Funder
National Natural Science Foundation of China
Publisher
Informa UK Limited
Subject
Cell Biology,Developmental Biology,Molecular Biology
Link
https://www.tandfonline.com/doi/pdf/10.1080/15384101.2022.2154551
Reference23 articles.
1. Cancer statistics, 2022
2. Immunotherapy for the Treatment of Urothelial Carcinoma
3. Macrophage targeting: opening new possibilities for cancer immunotherapy
4. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
5. Effects of extracellular matrix viscoelasticity on cellular behaviour
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination;Cancer Letters;2024-07
2. Identification of Multi-landscape and Cell Interactions in the Tumor Microenvironment through High-Coverage Single-Cell Sequencing;2024-06-22
3. Identification and validation of COL6A1 as a novel target for tumor electric field therapy in glioblastoma;CNS Neuroscience & Therapeutics;2024-06
4. Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8+ T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine-learning bioinformatics retrospective study;International Journal of Surgery;2024-05-17
5. Construction and analysis of a reliable five-gene prognostic signature for colon adenocarcinoma associated with the wild-type allelic state of the COL6A6 gene;Translational Cancer Research;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3